Targos Molecular Pathology GmbH

We are the biospecimen and biomarker specialistsTM Discovery Life Sciences combines the worlds largest biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions. Our robust biospecimen and biomarker platform is optimized for speed and large-scale capacity. We routinely manage hundreds of studies and expertly test thousands of biospecimens simultaneously as a single vendor - eliminating time-consuming and inefficient transfers of biospecimens or data between different vendors. Leading biopharma, diagnostic and academic institutions trust us to quickly deliver high-quality biospecimens and reliable, reproducible biomarker data, so they...

Molecular pathology,biomarker,clinical trials,digital pathology,sequencing,and mutation analysis

Targos molecular pathology gmbh operates in the Biotechnology research industry.

Targos molecular pathology gmbh's revenue is 11m - 100m

Targos molecular pathology gmbh has 11 - 50 employees.